Allievex Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Liquidation

Allievex General Information

Description

Developer of novel therapies designed for the treatment of rare pediatric neurodegenerative diseases. The company's therapy is an investigational enzyme replacement drug that uses a novel fusion of recombinant human alpha-N-acetyglucosaminidase with a peptide derived from the insulin-like growth factor, enabling physicians to treat children with rare and devastating neurological diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • P.O. Box 1056
  • Marblehead, MA 01945
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • P.O. Box 1056
  • Marblehead, MA 01945
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allievex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 24-Jul-2024 Completed Bankruptcy: Liquidation
3. Later Stage VC (Series A2) 15-Feb-2022 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A1) 01-Jul-2020 $19.1M $44.1M Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 23-Oct-2019 $25M $25M Completed Clinical Trials - Phase 3
To view Allievex’s complete valuation and funding history, request access »

Allievex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Allievex’s complete cap table history, request access »

Allievex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapies designed for the treatment of rare pediatric neurodegenerative diseases. The company's ther
Drug Discovery
Marblehead, MA
8 As of 2022

Cleveland, OH
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allievex Competitors (3)

One of Allievex’s 3 competitors is Abeona Therapeutics, a Corporation company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abeona Therapeutics Corporation Cleveland, OH
Denali Therapeutics Formerly VC-backed South San Francisco, CA
JCR Pharmaceuticals Corporation Ashiya, Japan
You’re viewing 3 of 3 competitors. Get the full list »

Allievex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allievex FAQs

  • When was Allievex founded?

    Allievex was founded in 2017.

  • Where is Allievex headquartered?

    Allievex is headquartered in Marblehead, MA.

  • What is the size of Allievex?

    Allievex has 8 total employees.

  • What industry is Allievex in?

    Allievex’s primary industry is Drug Discovery.

  • Is Allievex a private or public company?

    Allievex is a Private company.

  • What is Allievex’s current revenue?

    The current revenue for Allievex is .

  • How much funding has Allievex raised over time?

    Allievex has raised $48.7M.

  • Who are Allievex’s competitors?

    Abeona Therapeutics, Denali Therapeutics, and JCR Pharmaceuticals are competitors of Allievex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process